↓ Skip to main content

Cochrane Database of Systematic Reviews

What is this page? Embed badge

Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease

Overview of attention for article published in Cochrane database of systematic reviews, January 2001
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
89 Mendeley
Summary Twitter Dimensions citations
Title
Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease
Published in
Cochrane database of systematic reviews, January 2001
DOI 10.1002/14651858.cd002881
Pubmed ID
11279770
Authors

Paul Jones, Michael Greenstone

Abstract

Carbonic anhydrase inhibitors such as acetazolamide cause a mild metabolic acidosis and may stimulate breathing. Some patients with severe chronic obstructive pulmonary disease (COPD) develop chronic hypercapnic ventilatory failure. In theory, they may benefit from use of these drugs with a fall in arterial carbon dioxide level (PCO2) and a rise in arterial oxygen (PO2).

View on publisher site

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Unknown 88 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 16%
Student > Bachelor 10 11%
Student > Postgraduate 8 9%
Student > Master 8 9%
Other 5 6%
Other 18 20%
Unknown 26 29%
Readers by discipline Count As %
Medicine and Dentistry 41 46%
Nursing and Health Professions 9 10%
Economics, Econometrics and Finance 2 2%
Social Sciences 2 2%
Pharmacology, Toxicology and Pharmaceutical Science 1 1%
Other 4 4%
Unknown 30 34%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 March 2014.
All research outputs
#15,298,293
of 22,751,628 outputs
Outputs from Cochrane database of systematic reviews
#10,779
of 12,315 outputs
Outputs of similar age
#95,959
of 113,323 outputs
Outputs of similar age from Cochrane database of systematic reviews
#30
of 40 outputs
Altmetric has tracked 22,751,628 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,315 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 8th percentile – i.e., 8% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 113,323 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 3rd percentile – i.e., 3% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.

This page is hosted by Altmetric on behalf of Cochrane Library.